Lo screening di Fabry nei pazienti con CKD di eziologia incerta e in terapia sostitutiva renale è una strategia efficace per identificare casi non...

Circulating tumor DNA (ctDNA) has offered a minimally invasive approach for the detection and measurement of cancer

This makes an interdisciplinary approach mandatory for the management of these patients, to provide the best care possible based on tumor size, site...